(Q37719543)

22 August 2017

1 reference

title

Does highly active antiretroviral therapy improve neurocognitive function? A systematic review (English)

1 reference

22 August 2017

main subject

anti-retroviral agent

0 references

1 reference

4

1 reference

22 August 2017

5

Alan J Flisher

1 reference

22 August 2017

2

Hetta Gouse

1 reference

22 August 2017

1

John A Joska

1 reference

22 August 2017

Robert H Paul

3

1 reference

22 August 2017

publication date

1 March 2010

1 reference

22 August 2017

published in

Journal of NeuroVirology

1 reference

22 August 2017

volume

16

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

101-114

1 reference

https://scigraph.springernature.com/pub.10.3109/13550281003682513

22 August 2017

exact match

0 references

cites work

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

1 reference

12 December 2020

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

1 reference

12 December 2020

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

12 December 2020

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

1 reference

12 December 2020

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis

1 reference

12 December 2020

Equivalency of Spanish language versions of the trail making test part B including or excluding "CH".

1 reference

12 December 2020

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

1 reference

12 December 2020

Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif

1 reference

12 December 2020

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

1 reference

12 December 2020

Response to systemic HIV viral load suppression correlates with psychomotor speed performance.

1 reference

12 December 2020

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

1 reference

12 December 2020

Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study

1 reference

12 December 2020

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection

1 reference

12 December 2020

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

1 reference

12 December 2020

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

The prevalence and incidence of neurocognitive impairment in the HAART era.

1 reference

12 December 2020

Evaluation of neuropsychological performance of HIV-infected patients with minor motor cognitive dysfunction treated with highly active antiretroviral therapy

1 reference

12 December 2020

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

1 reference

12 December 2020

HIV dementia: an evolving disease

1 reference

12 December 2020

Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study

1 reference

12 December 2020

Advantages and disadvantages of separate norms for African Americans

1 reference

12 December 2020

Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy.

1 reference

12 December 2020

Challenges to the diagnosis and management of HIV dementia

1 reference

12 December 2020

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

1 reference

12 December 2020

Evolution of HIV dementia with HIV infection

1 reference

12 December 2020

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

Longitudinal Improvement in Psychomotor Processing Speed Is Associated With Potent Combination Antiretroviral Therapy in HIV-1 Infection

1 reference

12 December 2020

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

1 reference

12 December 2020

Neurocognitive disturbances in HIV.

1 reference

12 December 2020

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

1 reference

12 December 2020

Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex

1 reference

12 December 2020

Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.

1 reference

12 December 2020

The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis.

1 reference

12 December 2020

Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine

1 reference

12 December 2020

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India

1 reference

12 December 2020

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

12 December 2020

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

12 December 2020

Highly active antiretroviral therapy improves neurocognitive functioning

1 reference

12 December 2020

Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors

1 reference

12 December 2020

HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study

1 reference

12 December 2020

Practice and drop-out effects during a 17-year longitudinal study of cognitive aging.

1 reference

12 December 2020

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda

1 reference

12 December 2020

Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection

1 reference

12 December 2020

Human immunodeficiency virus type 1 subtypes differ in disease progression

1 reference

12 December 2020

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

12 December 2020

Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders

1 reference

12 December 2020

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

1 reference

12 December 2020

10.3109/13550281003682513

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

1070985843

0 references

1 reference